Literature DB >> 9663622

Syringe use and reuse: effects of syringe exchange programs in four cities.

R Heimer1, K Khoshnood, D Bigg, J Guydish, B Junge.   

Abstract

We determined the effect of syringe exchange programs (SEPs) on syringe reuse patterns. Five methods were employed to estimate injections per syringe made by exchange clients in four cities. In San Francisco, Chicago, and Baltimore, self-reported data on the number of injections per syringe were obtained. In New Haven, self-reported injection frequencies were combined with syringe tracking data to derive two methods for estimating the mean injections per syringe. The average number of injections per syringe declined by at least half after establishment of SEPs in New Haven, Baltimore, and Chicago, all cities where such an analysis could be made. There were significant increases in the percentages of exchangers reporting once-only use of their syringes in San Francisco, Baltimore, and Chicago, all cities where the data were amenable to this form of analysis. Self-report and syringe tracking estimates were in agreement that SEP participation was associated with decreases in syringe reuse by drug injectors. SEP participation was associated with increases in the once-only use of syringes. These findings add to earlier studies supporting the role of SEPs in reducing the transmission of syringe-borne infections such as HIV and hepatitis.

Entities:  

Mesh:

Year:  1998        PMID: 9663622     DOI: 10.1097/00042560-199802001-00008

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  18 in total

1.  Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994-1998.

Authors:  H Brahmbhatt; D Bigg; S A Strathdee
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

2.  Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.

Authors:  Robert Heimer; Scott Clair; Wei Teng; Lauretta E Grau; Kaveh Khoshnood; Merrill Singer
Journal:  J Urban Health       Date:  2002-12       Impact factor: 3.671

3.  Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies.

Authors:  Traci C Green; Ricky N Bluthenthal; Merrill Singer; Leo Beletsky; Lauretta E Grau; Patricia Marshall; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

4.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

5.  Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients.

Authors:  Ricky N Bluthenthal; Rachel Anderson; Neil M Flynn; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

Review 6.  Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward.

Authors:  Mukta Sharma; Dave Burrows; Ricky Bluthenthal
Journal:  Int J Drug Policy       Date:  2007-01-02

7.  Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.

Authors:  Robert Heimer
Journal:  Int J Drug Policy       Date:  2008-01-18

8.  Barriers to practicing risk reduction strategies among people who inject drugs.

Authors:  Kristina T Phillips
Journal:  Addict Res Theory       Date:  2015-07-21

Review 9.  Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.

Authors:  David H Cloud; Tessie Castillo; Lauren Brinkley-Rubinstein; Manisha Dubey; Robert Childs
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

Review 10.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.